Insider Transactions in Q3 2023 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2023
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,467
-5.43%
|
$24,939
$17.23 P/Share
|